+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
ID07226999

Global Phase 23 Study of PF-08634404 Combined With Chemotherapy Versus Atezolizumab Plus Chemotherapy in Adults With Extensive-Stage Small Cell Lung Cancer

Led by Pfizer · Updated on 2026-10-08

550

Participants Needed

82

Research Sites

195 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying a new medicine called PF-08634404 to see how well it works when combined with chemotherapy in adults who have extensive-stage small cell lung cancer ES-SCLC, a fast-growing type of lung cancer that has spread widely. This study includes two parts the first part focuses on checking the safety and tolerance of the medicine with chemotherapy, while the second part compares this combination to an approved treatment using atezolizumab and chemotherapy. Participants will receive treatments through intravenous infusions in repeated cycles. Some participants may continue receiving PF-08634404 alone after the initial combined treatment phase. The study involves random assignment to either the PF-08634404 plus chemotherapy group or the atezolizumab plus chemotherapy group. During the study, participants will have regular assessments including scans to measure tumor response, physical exams, laboratory tests, and questionnaires to evaluate quality of life. The researchers will track outcomes such as tumor shrinkage, overall survival, adverse events, and treatment tolerance up to about two years after treatment completion. Safety and drug concentration in the blood will also be monitored closely throughout the trial.

CONDITIONS

Brief Title

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Research Team

P

Pfizer CT.gov Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here